Evidence map›Paper›PMID 33528996›Full record

ArticleAnalytical chemistry2021

Sequential Ensemble-Decision Aliquot Ranking Isolation and Fluorescence

Shihan Xu, Li Wu, Yuling Qin, Yifei Jiang, Kai Sun, Chenee Holcomb, Michael G Gravett, Lucia Vojtech, Perry G Schiro, Daniel T Chiu

Abstract read
In one paragraph

Article in Analytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shihan XuDepartment of Bioengineering, University of Washington, Seattle, Washington 98105, United States.ORCID 0000-0002-0938-6902
Li WuDepartment of Chemistry, University of Washington, Seattle, Washington 98195-1700, United States.ORCID 0000-0002-4118-7970
Yuling QinDepartment of Chemistry, University of Washington, Seattle, Washington 98195-1700, United States.
Yifei JiangDepartment of Chemistry, University of Washington, Seattle, Washington 98195-1700, United States.ORCID 0000-0003-1818-4541
Kai SunDepartment of Chemistry, University of Washington, Seattle, Washington 98195-1700, United States.ORCID 0000-0002-1109-8934
Chenee HolcombDepartment of Obstetrics & Gynecology, University of Washington, Seattle, Washington 98195-0005, United States.
Michael G GravettDepartment of Obstetrics & Gynecology, University of Washington, Seattle, Washington 98195-0005, United States.
Lucia VojtechDepartment of Obstetrics & Gynecology, University of Washington, Seattle, Washington 98195-0005, United States.ORCID 0000-0003-2343-0719
Perry G SchiroMiCareo Inc., Xing-Ai Road Ln. 77 No. 69 5F, Taipei City 114, Taiwan.
Daniel T ChiuDepartment of Bioengineering, University of Washington, Seattle, Washington 98105, United States.ORCID 0000-0003-2964-9578

Funding

Placentomics using a novel method to isolate circulating placental derivativesR01HD089679 · NICHD · UNIVERSITY OF WASHINGTON · PI CHIU, DANIEL T, GRAVETT, MICHAEL G · 2016 to 2020
$3.1M
NICHD NIH HHS R01 HD089679
6 · The paper itself

Abstract

Isolation and analysis of circulating rare cells is a promising approach for early detection of cancer and other diseases and for prenatal diagnosis. Isolation of rare cells is usually difficult due to their heterogeneity as well as their low abundance in peripheral blood. We previously reported a two-stage ensemble-decision aliquot ranking platform (S-eDAR) for isolating circulating tumor cells from whole blood with high throughput, high recovery rate (>90%), and good purity (>70%), allowing detection of low surface antigen-expressing cancer cells linked to metastasis. However, due to the scarcity of these cells, large sample volumes and large quantities of antibodies were required to isolate sufficient cells for downstream analysis. Here, we drastically increased the number of nucleated cells analyzed by first concentrating peripheral blood mononuclear cells (PBMCs) from whole blood by density gradient centrifugation. The S-eDAR platform was capable of isolating rare cells from concentrated PBMCs (10

Indexed as

Leukocytes, MononuclearNeoplastic Cells, CirculatingCell SeparationFemaleFetal BloodHumansIn Situ Hybridization, FluorescenceLeukocytesPregnancy

Identifiers

PMID33528996
PMCPMC9901914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.